Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 11006285)

Published in J Biol Chem on December 15, 2000

Authors

E Brin1, J Yi, A M Skalka, J Leis

Author Affiliations

1: Department of Microbiology and Immunology, Northwestern University School of Medicine, Chicago, Illinois 60611, USA.

Articles citing this

Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol (2004) 1.84

Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol (2004) 1.79

Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J Virol (2002) 1.68

Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J Virol (2003) 1.61

Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci (2008) 1.50

Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc Natl Acad Sci U S A (2003) 1.48

Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology (2008) 1.48

Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) (2009) 1.37

The role of unintegrated DNA in HIV infection. Retrovirology (2011) 1.23

Methods for integration site distribution analyses in animal cell genomes. Methods (2008) 1.21

Nucleoprotein complex intermediates in HIV-1 integration. Methods (2009) 1.03

A three-dimensional model of the human immunodeficiency virus type 1 integration complex. J Comput Aided Mol Des (2005) 1.02

Effect of DNA repair protein Rad18 on viral infection. PLoS Pathog (2006) 0.99

Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase. Retrovirology (2009) 0.99

The Rad27 (Fen-1) nuclease inhibits Ty1 mobility in Saccharomyces cerevisiae. Genetics (2003) 0.92

Retroviral DNA Integration. Chem Rev (2016) 0.90

Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells. J Virol (2011) 0.89

Subcellular localization and integration activities of rous sarcoma virus reverse transcriptase. J Virol (2002) 0.89

DNA double strand break repair enzymes function at multiple steps in retroviral infection. Retrovirology (2009) 0.89

Cooperation between reverse transcriptase and integrase during reverse transcription and formation of the preintegrative complex of Ty1. Eukaryot Cell (2006) 0.86

Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51. Nucleic Acids Res (2006) 0.85

Raltegravir: molecular basis of its mechanism of action. Eur J Med Res (2009) 0.82

DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition. Retrovirology (2013) 0.81

Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive update. AIDS Res Ther (2017) 0.75

Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chem Biol (2015) 0.75

Articles by these authors

The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell (1990) 7.19

The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol (1989) 6.83

Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77

Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31

An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83

Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39

The retroviral enzymes. Annu Rev Biochem (1994) 4.21

Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol (1996) 3.97

A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95

Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements. Cell (1980) 3.53

Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol Cell Biol (1990) 3.18

Isolation and characterization of an endonuclease from Escherichia coli specific for ribonucleic acid in ribonucleic acid-deoxyribonucleic acid hybrid structures. J Biol Chem (1973) 3.13

Nucleotide sequence of acceptor site and termini of integrated avian endogenous provirus ev1: integration creates a 6 bp repeat of host DNA. Cell (1981) 3.10

HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science (1986) 3.06

Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol (1992) 3.06

Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04

Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature (1989) 2.72

Nucleotide sequence of noncoding regions in Rous-associated virus-2: comparisons delineate conserved regions important in replication and oncogenesis. J Virol (1984) 2.71

A role for DNA-PK in retroviral DNA integration. Science (1999) 2.68

Avian sarcoma and leukosis virus pol-endonuclease recognition of the tandem long terminal repeat junction: minimum site required for cleavage is also required for viral growth. J Virol (1987) 2.62

A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J Virol (1988) 2.62

The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev (1991) 2.58

Generation of diversity in retroviruses. Annu Rev Genet (1990) 2.53

Site-directed mutagenesis using overlap extension PCR. Methods Mol Biol (1996) 2.49

Retroviral integrase functions as a multimer and can turn over catalytically. J Biol Chem (1992) 2.48

Identification of a putative alternate sigma factor and characterization of a multicomponent regulatory cascade controlling the expression of Pseudomonas syringae pv. syringae Pss61 hrp and hrmA genes. J Bacteriol (1994) 2.45

Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts. J Virol (1981) 2.45

Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the alpha beta form of avian reverse transcriptase. Proc Natl Acad Sci U S A (1983) 2.40

Retroviral DNA H structures: displacement-assimilation model of recombination. Cell (1982) 2.37

Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol (1991) 2.26

Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25

Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12. Mutation which affects RNA binding in vitro blocks viral replication. J Biol Chem (1988) 2.25

High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol (1995) 2.16

Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol (1991) 2.16

Isolation and characterization of recombinant DNA clones of avian retroviruses: size heterogeneity and instability of the direct repeat. J Virol (1980) 2.15

Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics. Infect Immun (2000) 2.15

Circles with two tandem long terminal repeats are specifically cleaved by pol gene-associated endonuclease from avian sarcoma and leukosis viruses: nucleotide sequences required for site-specific cleavage. J Virol (1985) 2.08

A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol (1994) 2.07

HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv Virus Res (1999) 2.06

Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli. J Virol (1988) 2.03

Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. Biotechniques (1993) 2.02

Characteristics and regulation of interaction of avian retrovirus pp12 protein with viral RNA. J Virol (1983) 1.94

DNA replication--bacteriophage lambda. Curr Top Microbiol Immunol (1977) 1.92

Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90

Sequence comparison in the crossover region of an oncogenic avian retrovirus recombinant and its nononcogenic parent: genetic regions that control growth rate and oncogenic potential. Mol Cell Biol (1982) 1.89

cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control. J Virol (1988) 1.88

Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis. J Virol (1981) 1.87

Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain. J Virol (1987) 1.85

Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci U S A (1986) 1.83

Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog. Mol Cell Biol (1981) 1.78

Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers". Proc Natl Acad Sci U S A (1988) 1.76

Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol (1996) 1.72

HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol (1999) 1.71

Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun (2003) 1.70

Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas. J Virol (1982) 1.70

Mechanism of action of the endonuclease associated with the alpha beta and beta beta forms of avian RNA tumor virus reverse transcriptase. J Virol (1983) 1.70

Ion-dependent inactivation of barium current through L-type calcium channels. J Gen Physiol (1997) 1.67

The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure (1996) 1.64

Retroviral DNA integration. Microbiol Mol Biol Rev (1999) 1.64

A covalent complex between retroviral integrase and nicked substrate DNA. Proc Natl Acad Sci U S A (1991) 1.61

Molecular modeling of the HIV-1 protease and its substrate binding site. Science (1989) 1.60

Retroviral integrase, putting the pieces together. J Biol Chem (1996) 1.58

HIV DNA integration: observations and interferences. J Acquir Immune Defic Syndr (1990) 1.54

Molecular mechanisms in retrovirus DNA integration. Antiviral Res (1997) 1.54

Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses. Mol Cell Biol (2001) 1.53

Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol (1996) 1.50

Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J Virol (1991) 1.48

Role of the avian retrovirus mRNA leader in expression: evidence for novel translational control. Mol Cell Biol (1986) 1.47

Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol (1982) 1.47

Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J Biol Chem (1997) 1.47

Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles. Virology (1996) 1.45

Synthetic peptides as substrates and inhibitors of a retroviral protease. Proc Natl Acad Sci U S A (1988) 1.41

Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J Biol Chem (1993) 1.40

Effects of phosphorylation of avian retrovirus nucleocapsid protein pp12 on binding of viral RNA. J Biol Chem (1984) 1.37

Genetic recombination in avian retroviruses. J Cell Biochem (1982) 1.37

Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase. J Biol Chem (1995) 1.35

Activity of avian retroviral protease expressed in Escherichia coli. J Virol (1988) 1.34

Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle. Infect Immun (2001) 1.34

Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J Virol (1997) 1.34

A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication. J Virol (1988) 1.30

Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. J Biol Chem (1989) 1.29

Biological activity of cloned retroviral DNA in microinjected cells. Proc Natl Acad Sci U S A (1981) 1.29

Inactivation of gating currents of L-type calcium channels. Specific role of the alpha 2 delta subunit. J Gen Physiol (1998) 1.27

Cyanogen bromide digestion of the avian myeloblastosis virus pp19 protein: isolation of an amino-terminal peptide that binds to viral RNA. J Virol (1983) 1.27

Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation. Mol Cell Biol (1985) 1.26